Crossmark

Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience

Crossref DOI link: https://doi.org/10.1007/s00381-019-04117-z

Published Online: 2019-03-21

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schiavetti, Amalia https://orcid.org/0000-0001-7792-7910
Varrasso, Giulia

Mollace, Maria Giovanna

Dominici, Carlo

Ferrara, Eva

Papoff, Paola

Di Biasi, Claudio
License Information

Text and Data Mining valid from 2019-03-21
More Information

Article History

Received: 11 January 2019

Accepted: 8 March 2019

First Online: 21 March 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.